HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $3,575,000 | +78.7% | 83,719 | +10.0% | 0.01% | +57.1% |
Q3 2020 | $2,001,000 | +15.3% | 76,121 | +17.6% | 0.01% | +16.7% |
Q2 2020 | $1,735,000 | +80.4% | 64,709 | +21.0% | 0.01% | +50.0% |
Q1 2020 | $962,000 | +18.5% | 53,464 | +16.8% | 0.00% | +33.3% |
Q4 2019 | $812,000 | +40.2% | 45,779 | +22.6% | 0.00% | +50.0% |
Q3 2019 | $579,000 | +25.9% | 37,333 | +39.5% | 0.00% | 0.0% |
Q2 2019 | $460,000 | +11.4% | 26,756 | +4.4% | 0.00% | 0.0% |
Q1 2019 | $413,000 | +20.4% | 25,636 | +9.2% | 0.00% | 0.0% |
Q4 2018 | $343,000 | +12.5% | 23,467 | +39.9% | 0.00% | +100.0% |
Q3 2018 | $305,000 | +15.5% | 16,777 | +7.2% | 0.00% | 0.0% |
Q2 2018 | $264,000 | -24.1% | 15,643 | -12.0% | 0.00% | -50.0% |
Q1 2018 | $348,000 | -0.9% | 17,769 | +2.4% | 0.00% | 0.0% |
Q4 2017 | $351,000 | +29.5% | 17,347 | +11.1% | 0.00% | 0.0% |
Q3 2017 | $271,000 | -26.8% | 15,618 | -45.8% | 0.00% | 0.0% |
Q2 2017 | $370,000 | +96.8% | 28,823 | +99.2% | 0.00% | +100.0% |
Q1 2017 | $188,000 | +34.3% | 14,470 | +2.5% | 0.00% | 0.0% |
Q4 2016 | $140,000 | -36.4% | 14,120 | -22.3% | 0.00% | -50.0% |
Q3 2016 | $220,000 | +107.5% | 18,178 | +48.4% | 0.00% | +100.0% |
Q2 2016 | $106,000 | -25.4% | 12,252 | +16.0% | 0.00% | 0.0% |
Q3 2015 | $142,000 | -33.6% | 10,566 | +11.7% | 0.00% | -50.0% |
Q2 2015 | $214,000 | – | 9,459 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |